Aspirin

BreastfeedingPediatric
  • TRADE NAMES: Aggrenox (Boehringer Ingelheim); Alka-Seltzer; Anacin (Wyeth); ASA; Ascriptin (Novartis, Wallace); Aspergum; Aspro; ASS; Bex; Caprin; Claragine; Coricidin D; Darvon Compound (aaiPharma); Disprin; Durlaza (New Haven); Ecotrin (GSK); Empirin; Equagesic (Women First); Excedrin (Bristol-Myers Squibb); Fiorinal (Watson); Gelprin; Halfprin; Measurin; Norgesic (3M); Novasen; Rhonal; Robaxisal; Soma Compound (MedPointe); Talwin Compound (Sanofi-Aventis); Vanquish; Yosprala (Aralez)
  • INDICATIONS: Pain, fever, inflammation
  • SYNONYM: acetylsalicylic acid; ASA
  • CLASS: Antiplatelet, Non-steroidal anti-inflammatory (NSAID), Salicylate
  • HALF-LIFE: 15–20 minutes

NSAIDs may cause an increased risk of serious cardiovascular and gastrointestinal adverse events, which can be fatal. This risk may increase with duration of use.

Aggrenox is aspirin and dipyridamole; Yosprala is aspirin and omeprazole.

Our database has 109 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
HAIR.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
OCULAR.
OTIC.
RENAL.
RESPIRATORY.
OTHER.


Page last updated 07/10/2019

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top